Qbic Fund

Qbic Fund is a Ghent-based venture capital firm that backs spin-off companies arising from the Ghent, Brussels and Antwerp university networks and affiliated research institutes, including VITO. It maintains strategic partnerships with these universities and VITO to gain early access to promising research and to support portfolio ventures from assessment to hands-on development. The firm focuses on life sciences, new materials, and information technology, with emphasis on software, deeptech, biotech and medtech opportunities. Through its university and research collaborations, Qbic Fund provides technical guidance and industry connections to help startups accelerate commercialization and growth.

Vincent Lenders

Investment Analyst

Cédric Van Nevel

Partner

Tom Smets

Investment Analyst

57 past transactions

Aloxy

Venture Round in 2025
Aloxy specializes in Industrial Internet of Things (IIoT) solutions, focusing on monitoring manual valve positions in various process industries such as chemical, oil, and gas. Their services include valve position monitoring, emergency shower monitoring, line blind tracking, device management, network monitoring, and ensuring data integrity.

Pleevi

Pre Seed Round in 2025
Pleevi specializes in optimizing electric vehicle (EV) charging for large parking facilities. It provides an AI-driven software solution that intelligently schedules charging sessions, considering local energy generation, pricing, and building load constraints. This ensures cheaper, greener charging while maintaining driver convenience, as vehicles are fully charged by the time drivers are ready to depart.

Swave Photonics

Series A in 2025
Swave Photonics designs and markets holographic chips based on proprietary diffractive photonics technology to power compact, lightweight, high-resolution displays that seamlessly blend digital content with the real world. As a fabless semiconductor company, it advances NanoPixel technology to enable immersive holographic displays for augmented reality and metaverse applications, targeting display manufacturers and content creators. The goal is to provide tools that visualize complex content, enable collaboration, and expand possibilities for immersive AR experiences.

Weavely

Seed Round in 2024
Weavely is a Figma plugin that creates, customizes, and publishes AI-generated forms and surveys, after which replies are collected.

Confo Therapeutics

Series B in 2024
Confo Therapeutics is a drug discovery company based in Brussels, Belgium, founded in 2015. The company specializes in developing internal drug discovery programs focused on G-protein coupled receptors (GPCRs) to address unmet medical needs. Utilizing its proprietary CONFO technology, Confo Therapeutics stabilizes the inherently unstable functional conformations of GPCRs, providing a robust framework for drug discovery. This innovative approach reveals previously inaccessible structural features of these receptors, facilitating the discovery of novel agonists and enhancing therapeutic interventions. By concentrating on stabilizing GPCRs, Confo Therapeutics aims to significantly advance the development of new treatments in the medical field.

Flindr Therapeutics

Series A in 2024
Flindr Therapeutics, a private biotech company develops next-generation precision oncology treatments.

AmphiStar

Seed Round in 2024
AmphiStar is a biotechnology company that produces sophorolipid products using biobased waste and side streams. Its core technology platform facilitates the transition from fossil-based to bio-based industries by utilizing sustainable, renewable raw materials like glucose, fatty acids, crude glycerine, and food waste.

VoxelSensors

Seed Round in 2024
VoxelSensors develops sensing technology for spatial and empathic interfaces and for mobile, XR, and industrial applications. Its proprietary Single Photon Active Event Sensor SPAES technology uses Single-Photon Avalanche Diodes to deliver low-power, low-latency data for precise spatial awareness and gaze tracking, enabling immersive experiences and intuitive interaction across consumer electronics, smartphones, wearables, and industrial contexts. The technology enables a new category of efficient three-dimensional perception by capturing a voxel with very few photons, delivering ultra-low power consumption and fast response times.

Tanai Therapeutics

Seed Round in 2023
Tanai Therapeutics develops novel therapeutics for people living with obesity and obesity-related complications.

Swave Photonics

Seed Round in 2023
Swave Photonics designs and markets holographic chips based on proprietary diffractive photonics technology to power compact, lightweight, high-resolution displays that seamlessly blend digital content with the real world. As a fabless semiconductor company, it advances NanoPixel technology to enable immersive holographic displays for augmented reality and metaverse applications, targeting display manufacturers and content creators. The goal is to provide tools that visualize complex content, enable collaboration, and expand possibilities for immersive AR experiences.

Hysopt

Seed Round in 2022
Hysopt develops software for HVAC designers, aiming to enhance system performance, reduce energy consumption, and lower carbon emissions. Its simulation tools help engineering firms, architects, and builders optimize heating and cooling systems.

Weavely

Pre Seed Round in 2022
Weavely is a Figma plugin that creates, customizes, and publishes AI-generated forms and surveys, after which replies are collected.

Morrow Optics

Angel Round in 2022
Our view is a world where nothing is missed and one pair does it all. Because there’s more to see than ever before, and you deserve to see the bigger picture without edges or limitations. Our story starts with Jelle De Smet and Paul Marchal, two pioneers who with combined experience in electronics and nanotechnology invented the Autofocal lens. They saw a better way, where ageing eyesight is no longer a burden and progressive lenses were a prequel. And so Morrow was founded in 2016 — followed by years of research, development and meticulous fine-tuning. We now launch our flagship Autofocal Eyewear that combines Active Liquid Crystal and a two-layer corrective lens to transform your vision — both near and far — at the touch of a button. In our eyes, independence is a state of mind. It’s the unshackled freedom to do what you want and on your own terms, whilst always improving. Discover why there is always mor’ to see.

VoxelSensors

Seed Round in 2022
VoxelSensors develops sensing technology for spatial and empathic interfaces and for mobile, XR, and industrial applications. Its proprietary Single Photon Active Event Sensor SPAES technology uses Single-Photon Avalanche Diodes to deliver low-power, low-latency data for precise spatial awareness and gaze tracking, enabling immersive experiences and intuitive interaction across consumer electronics, smartphones, wearables, and industrial contexts. The technology enables a new category of efficient three-dimensional perception by capturing a voxel with very few photons, delivering ultra-low power consumption and fast response times.

Swave Photonics

Seed Round in 2022
Swave Photonics designs and markets holographic chips based on proprietary diffractive photonics technology to power compact, lightweight, high-resolution displays that seamlessly blend digital content with the real world. As a fabless semiconductor company, it advances NanoPixel technology to enable immersive holographic displays for augmented reality and metaverse applications, targeting display manufacturers and content creators. The goal is to provide tools that visualize complex content, enable collaboration, and expand possibilities for immersive AR experiences.

Aloxy

Venture Round in 2022
Aloxy specializes in Industrial Internet of Things (IIoT) solutions, focusing on monitoring manual valve positions in various process industries such as chemical, oil, and gas. Their services include valve position monitoring, emergency shower monitoring, line blind tracking, device management, network monitoring, and ensuring data integrity.

EyeD Pharma

Venture Round in 2021
EyeD Pharma SA is a pharmaceutical company based in Liège, Belgium, specializing in the development and commercialization of innovative drug products for ophthalmology. The company focuses primarily on the treatment of glaucoma, a condition historically managed with daily eye drops. EyeD Pharma aims to enhance the quality of life for patients by reducing the side effects associated with traditional therapies. In collaboration with ophthalmologists, the company offers new treatment options and surgical products that improve clinical practices and provide therapeutic assistance that is currently lacking in the market. Through its efforts, EyeD Pharma seeks to advance the standard of care in ophthalmology.

Crowd Scan

Series A in 2021
Crowd Scan offers crowd density prediction services and integrated crowd management solutions. It designs a solution for measuring and analysing crowd density in real-time using a wireless sensor network.

Trince

Seed Round in 2021
Trince specializes in advancing cell-based science and therapeutics. Its proprietary platform combines laser exposure with photothermal nanoparticles to facilitate the delivery of molecules into cells both in vitro and ex vivo, enabling efficient genetic material transfer.

Sentea

Venture Round in 2021
Sentea specializes in fiber optic sensing technology for structural health monitoring. Its solutions enable accurate prediction and prevention of equipment failure and structural damage, even in harsh environments. Additionally, Sentea's sensors improve operational efficiency by monitoring equipment and processes.

Accelleran

Series B in 2021
Accelleran, founded in 2013 and headquartered in Antwerp, Belgium, specializes in delivering Open RAN-aligned Private 5G networks tailored for enterprises of all sizes. The company focuses on providing an economically viable alternative to traditional mobile telecom solutions through its open and containerized radio access network (RAN) software. Accelleran’s offerings leverage cloud-native techniques that enhance flexibility, innovation, and scalability while maintaining hardware independence. By facilitating the deployment of multi-vendor, disaggregated Private 5G networks akin to WiFi, Accelleran empowers businesses to achieve real-time network control, automation, and an enhanced user experience. Through collaboration with a diverse ecosystem of partners, the company is positioned to support both private and public network needs effectively.

Aphea.Bio

Series B in 2021
Aphea.Bio is a company focused on developing next-generation biopesticides and biostimulants derived from natural microorganisms. Its biopesticides serve as an alternative to conventional chemical pesticides, addressing the increasing pressure on synthetic chemical use in agriculture. Additionally, the company creates biostimulants that enhance crop growth by improving the uptake of nutrients from the soil. Aphea.Bio's products aim to sustainably increase crop yields and health, specifically targeting crops such as maize and wheat. By utilizing proprietary technologies, the company accelerates the discovery of innovative biocontrol and biostimulant solutions, enabling farmers to manage pests, diseases, and fertilizer application more effectively.

Abscint

Seed Round in 2021
ABSCINT engages in the development of radiolabelled single-domain antibodies for whole-body molecular imaging applications. Molecular imaging is used for the diagnosis of disease, the molecular characterization of a disease, monitoring treatment response, and the detection of disease recurrence.

Aphea.Bio

Series B in 2020
Aphea.Bio is a company focused on developing next-generation biopesticides and biostimulants derived from natural microorganisms. Its biopesticides serve as an alternative to conventional chemical pesticides, addressing the increasing pressure on synthetic chemical use in agriculture. Additionally, the company creates biostimulants that enhance crop growth by improving the uptake of nutrients from the soil. Aphea.Bio's products aim to sustainably increase crop yields and health, specifically targeting crops such as maize and wheat. By utilizing proprietary technologies, the company accelerates the discovery of innovative biocontrol and biostimulant solutions, enabling farmers to manage pests, diseases, and fertilizer application more effectively.

Indigo Diabetes

Series B in 2020
Indigo Diabetes, established in 2016 and headquartered in Ghent, Belgium, specializes in developing innovative, non-invasive glucose monitoring solutions. The company's flagship product is an invisible, photonics-based sensor that is inserted under the skin, continuously measuring blood sugar levels, thereby eliminating the need for traditional finger pricks. Indigo Diabetes aims to enhance the lives of people with diabetes by providing accurate glucose monitoring with an improved user experience.

QustomDot

Seed Round in 2020
QustomDot is a company based in Ghent, Belgium, specializing in the development and manufacturing of on-chip grade, cadmium-free quantum dots. These tiny semiconductor nanoparticles are designed for color conversion, allowing them to transform ultraviolet or blue light into pure colors. QustomDot's products enhance image quality and energy efficiency in various applications, including LED and LCD television screens, smartphones, smartwatches, and virtual or augmented reality goggles. Founded in 2020, the company also supports clients in effectively integrating quantum dots into their products, thereby improving the overall display performance and capabilities.

MRM Health NV

Series A in 2020
MRM Health NV is a biopharmaceutical company based in Ghent, Belgium, specializing in the development of microbiome-based therapeutics aimed at treating metabolic diseases. Founded in early 2020 as a subsidiary of MRM Technologies N.V., the company focuses on innovative drug discovery, notably its lead candidate MH002, which targets Inflammatory Bowel Disease (IBD), encompassing conditions such as Ulcerative Colitis and Crohn's disease. MRM Health was established in collaboration with the Flemish Institute of Biotechnology, leveraging expertise in microbiome research to translate scientific discoveries into effective therapeutic applications.

Calltic

Series A in 2020
Calltic, founded in 2017 and based in Gent, Belgium, specializes in innovative fraud detection solutions for the telecom industry. The company employs advanced pattern recognition techniques to identify both on-net and off-net SIM boxes, providing a comprehensive approach to combat telecom fraud. By utilizing a single technology, Calltic enables its clients to swiftly and accurately detect fraudulent activities in international calls, significantly reducing the financial losses associated with such fraud. Through its unique offerings, Calltic aims to outperform traditional methods of call detail record profiling, positioning itself as a leader in the telco fraud prevention sector.

Biotalys

Series C in 2019
Biotalys is an agricultural technology company based in Ghent, Belgium, founded in 2013. The company specializes in researching and developing biopesticides designed to control pests and diseases on crops and harvested products. Biotalys employs its proprietary Agrobody technology platform to create protein-based biocontrol solutions that combine the effectiveness of chemical pesticides with the safety profile of biologicals. These solutions are suitable for both pre- and post-harvest applications, aiming to provide a more sustainable and safer food supply. The company's technology platform generates products that enable targeted delivery and retention of active ingredients to prevent and control weeds, pests, and diseases.

Unifly

Series B in 2019
Unifly is a developer of unmanned traffic management software focused on the secure integration of drones into global airspace. Founded in 2015 by aerospace experts, the company emerged from a vision shared by air traffic controllers who recognized the need for effective management of the increasing number of drones. Unifly's award-winning platform connects authorities and drone operators, allowing for real-time monitoring and management of drone traffic, while providing pilots with essential information regarding the legal status of their flights. The platform is already utilized by national authorities in Germany, Denmark, Austria, and Belgium, and Unifly is also active in the United States and several projects worldwide, including Africa and Asia. By fostering collaboration with various stakeholders, Unifly aims to enhance airspace safety and facilitate the seamless integration of drones into everyday life, addressing critical concerns regarding safety and oversight in both recreational and commercial drone activities.

EyeD Pharma

Funding Round in 2019
EyeD Pharma SA is a pharmaceutical company based in Liège, Belgium, specializing in the development and commercialization of innovative drug products for ophthalmology. The company focuses primarily on the treatment of glaucoma, a condition historically managed with daily eye drops. EyeD Pharma aims to enhance the quality of life for patients by reducing the side effects associated with traditional therapies. In collaboration with ophthalmologists, the company offers new treatment options and surgical products that improve clinical practices and provide therapeutic assistance that is currently lacking in the market. Through its efforts, EyeD Pharma seeks to advance the standard of care in ophthalmology.

iFLUX

Venture Round in 2019
iFLUX is a technology company focused on sustainable groundwater management and soil remediation. Founded in 2017, it addresses the critical issue of water scarcity by enhancing the visibility of groundwater dynamics. The company has developed patented groundwater sampling technology, known as iFLUX Samplers, which allows for efficient tracking of groundwater contamination over time. These samplers facilitate faster and more cost-effective remediation projects by providing essential data on groundwater and contaminant movement. iFLUX’s Sensing Solutions integrate advanced commercial sensors with unique vertical and horizontal flux sensors to create comprehensive real-time monitoring networks. These networks offer actionable insights through a personalized dashboard that combines public and company-specific data, enabling clients to analyze trends and respond promptly to groundwater-related activities. iFLUX serves various sectors, including urban management, conservation, construction, and drinking water utilities, providing them with critical information to mitigate risks associated with soil contamination and ensure reliable water supplies.

Aloxy

Series A in 2018
Aloxy specializes in Industrial Internet of Things (IIoT) solutions, focusing on monitoring manual valve positions in various process industries such as chemical, oil, and gas. Their services include valve position monitoring, emergency shower monitoring, line blind tracking, device management, network monitoring, and ensuring data integrity.

Hysopt

Seed Round in 2018
Hysopt develops software for HVAC designers, aiming to enhance system performance, reduce energy consumption, and lower carbon emissions. Its simulation tools help engineering firms, architects, and builders optimize heating and cooling systems.

Laminaria

Venture Round in 2017
Laminaria is a company based in Ostend, Belgium, founded in 2011, that specializes in the manufacturing of wave energy converter equipment. Through its innovative technology, Laminaria contributes to the renewable energy sector by harnessing ocean wave motion to generate power. The company focuses on developing systems that convert tilting and translating movements of waves into electrical energy, transferring this motion through mooring ropes to connected generators. As a leader in the field, Laminaria heads a consortium of ocean energy experts for the LAMWEC project, collaborating with organizations such as EMEC, Innosea, Ghent University, and TTI Testing to advance wave energy technology and its applications.

Blue Foot Membranes

Seed Round in 2017
Blue Foot Membranes is a start-up company founded in 2017 in Lommel, Limburg, specializing in the production and commercialization of the Integrated Permeate Channel (IPC™) technology. This patented technology is utilized in Membrane Bioreactors designed for the treatment of industrial and municipal wastewater. The company manufactures washable flat sheet membranes that offer enhanced fouling control, leading to improved filtration efficiency. By enabling effective physical cleaning of filtration systems, Blue Foot Membranes supports industries and municipalities in their efforts to reuse wastewater, contributing to more sustainable water management practices.

Sentiance

Series A in 2017
Sentiance is a data science company specializing in motion insights derived from IoT sensor data. It develops advanced technology that transforms motion data into contextual insights, enabling better understanding of individual behavior and real-time contexts. Sentiance serves various sectors, including motor insurance, ride-hailing, delivery services, automotive OEMs, and transport authorities. By employing on-device AI and behavioral change techniques, the company personalizes engagement strategies aimed at enhancing safety and sustainability in mobility. This innovative approach helps clients reduce accidents, improve claims handling, boost customer engagement and acquisition, enhance loss ratios, and implement tailored driver safety programs.

Aphea.Bio

Series A in 2017
Aphea.Bio is a company focused on developing next-generation biopesticides and biostimulants derived from natural microorganisms. Its biopesticides serve as an alternative to conventional chemical pesticides, addressing the increasing pressure on synthetic chemical use in agriculture. Additionally, the company creates biostimulants that enhance crop growth by improving the uptake of nutrients from the soil. Aphea.Bio's products aim to sustainably increase crop yields and health, specifically targeting crops such as maize and wheat. By utilizing proprietary technologies, the company accelerates the discovery of innovative biocontrol and biostimulant solutions, enabling farmers to manage pests, diseases, and fertilizer application more effectively.

PharmaFluidics

Venture Round in 2017
PharmaFluidics is a Brussels-based spin-off from the Vrije Universiteit Brussel, focusing on developing and manufacturing micro-chip based chromatography columns for use in biomarker, diagnostics, and drug research applications. The company leverages its expertise in chemical engineering and micro-fabrication technology to create high-quality solutions tailored for mixing, separation, and reaction processes at milli- to nano-scales. Their products enable researchers to identify active compounds in complex biological samples more efficiently and sensitively.

Indigo Diabetes

Series A in 2016
Indigo Diabetes, established in 2016 and headquartered in Ghent, Belgium, specializes in developing innovative, non-invasive glucose monitoring solutions. The company's flagship product is an invisible, photonics-based sensor that is inserted under the skin, continuously measuring blood sugar levels, thereby eliminating the need for traditional finger pricks. Indigo Diabetes aims to enhance the lives of people with diabetes by providing accurate glucose monitoring with an improved user experience.

Morrow Optics

Seed Round in 2016
Our view is a world where nothing is missed and one pair does it all. Because there’s more to see than ever before, and you deserve to see the bigger picture without edges or limitations. Our story starts with Jelle De Smet and Paul Marchal, two pioneers who with combined experience in electronics and nanotechnology invented the Autofocal lens. They saw a better way, where ageing eyesight is no longer a burden and progressive lenses were a prequel. And so Morrow was founded in 2016 — followed by years of research, development and meticulous fine-tuning. We now launch our flagship Autofocal Eyewear that combines Active Liquid Crystal and a two-layer corrective lens to transform your vision — both near and far — at the touch of a button. In our eyes, independence is a state of mind. It’s the unshackled freedom to do what you want and on your own terms, whilst always improving. Discover why there is always mor’ to see.

Molecubes

Seed Round in 2016
Molecubes is a spin-off from Ghent University, founded with the support of iMinds, specializing in the development of preclinical imaging systems. The company offers a modular benchtop platform designed for the flexible in vivo scanning of laboratory animals, enabling researchers to conduct high-performance SPECT/CT and PET/CT studies. Their innovative imaging cubes are compact enough to fit in various lab spaces, facilitating the combination of different imaging modalities. With a focus on user-friendly design, Molecubes provides intuitive wireless acquisition and reconstruction software, making the systems accessible to a wide range of users. The company's solutions prioritize ease of use and effective servicing, reflecting the insights of engineers who are also end-users, thereby enhancing the daily imaging practices of researchers in the field.

Smartnodes

Seed Round in 2016
SmartNodes S.A. is a Belgium-based company founded in 2014 that specializes in innovative lighting systems and solutions for urban environments. The company's flagship product, the smart lighting system (SLS-G3), includes components such as the node unit, power unit, and smart lighting control unit, along with additional offerings like the access point system and smart noise system. SmartNodes focuses on enhancing public safety and environmental sustainability through its technology, which allows for adaptive lighting that minimizes energy consumption and reduces light pollution while ensuring adequate visibility for road users. The company serves both public authorities and private sector clients, aiming to transform public lighting by providing efficient, eco-friendly, and intelligent solutions. As of July 2019, SmartNodes operates as a subsidiary of Lacroix SA.

Sentiance

Seed Round in 2015
Sentiance is a data science company specializing in motion insights derived from IoT sensor data. It develops advanced technology that transforms motion data into contextual insights, enabling better understanding of individual behavior and real-time contexts. Sentiance serves various sectors, including motor insurance, ride-hailing, delivery services, automotive OEMs, and transport authorities. By employing on-device AI and behavioral change techniques, the company personalizes engagement strategies aimed at enhancing safety and sustainability in mobility. This innovative approach helps clients reduce accidents, improve claims handling, boost customer engagement and acquisition, enhance loss ratios, and implement tailored driver safety programs.

Ovizio

Venture Round in 2015
Ovizio develops digital holographic interferometric microscopy products. It specializes in creating four-dimensional microscopic imaging devices and software based on digital holographic microscopy for life sciences research and bioprocessing.

Mind4Energy

Venture Round in 2015
Mind4Energy is a company founded by four engineers who are dedicated to providing high-quality services in the renewable energy sector, specifically focusing on photovoltaic systems. The company has developed a software solution designed to monitor, analyze, and optimize the performance of solar parks. This software tracks various metrics such as capacity, currents, voltages, and overall efficiency of photovoltaic plants. By generating performance reports and issuing alarms for any irregularities, Mind4Energy's technology enables customers to reduce operational costs, swiftly detect power losses, and effectively manage large solar installations. The company's mission is to contribute to the advancement of reliable and sustainable energy supply.

Unifly

Seed Round in 2015
Unifly is a developer of unmanned traffic management software focused on the secure integration of drones into global airspace. Founded in 2015 by aerospace experts, the company emerged from a vision shared by air traffic controllers who recognized the need for effective management of the increasing number of drones. Unifly's award-winning platform connects authorities and drone operators, allowing for real-time monitoring and management of drone traffic, while providing pilots with essential information regarding the legal status of their flights. The platform is already utilized by national authorities in Germany, Denmark, Austria, and Belgium, and Unifly is also active in the United States and several projects worldwide, including Africa and Asia. By fostering collaboration with various stakeholders, Unifly aims to enhance airspace safety and facilitate the seamless integration of drones into everyday life, addressing critical concerns regarding safety and oversight in both recreational and commercial drone activities.

CoScale

Venture Round in 2015
CoScale is a developer of a comprehensive performance monitoring platform tailored for production environments. The platform continuously tracks servers, containers, and applications, providing insights into their effects on user experience and key business metrics. By employing automated anomaly detection and contextual insights, CoScale simplifies the monitoring and troubleshooting processes for its users, enabling proactive responses to performance issues that could adversely impact business outcomes. The platform is designed for use by DevOps engineers, application owners, and business professionals, all of whom aim to enhance digital performance by ensuring faster and more reliable websites and applications. This ultimately leads to improved user experiences and increased conversion rates.

Confo Therapeutics

Venture Round in 2015
Confo Therapeutics is a drug discovery company based in Brussels, Belgium, founded in 2015. The company specializes in developing internal drug discovery programs focused on G-protein coupled receptors (GPCRs) to address unmet medical needs. Utilizing its proprietary CONFO technology, Confo Therapeutics stabilizes the inherently unstable functional conformations of GPCRs, providing a robust framework for drug discovery. This innovative approach reveals previously inaccessible structural features of these receptors, facilitating the discovery of novel agonists and enhancing therapeutic interventions. By concentrating on stabilizing GPCRs, Confo Therapeutics aims to significantly advance the development of new treatments in the medical field.

Sentiance

Seed Round in 2015
Sentiance is a data science company specializing in motion insights derived from IoT sensor data. It develops advanced technology that transforms motion data into contextual insights, enabling better understanding of individual behavior and real-time contexts. Sentiance serves various sectors, including motor insurance, ride-hailing, delivery services, automotive OEMs, and transport authorities. By employing on-device AI and behavioral change techniques, the company personalizes engagement strategies aimed at enhancing safety and sustainability in mobility. This innovative approach helps clients reduce accidents, improve claims handling, boost customer engagement and acquisition, enhance loss ratios, and implement tailored driver safety programs.

Biogazelle

Venture Round in 2014
Biogazelle offers expert laboratory services in nucleic acid quantification (gene expression, mutation, and copy number analysis, antisense oligonucleotide screening) to support its customers in their development of diagnostics and therapeutics. Customized workflows for clinically relevant samples – from liquid biopsies to fixed tissues – are available. In addition, Biogazelle’s advanced RNA biomarker development program offers an end-to-end solution from RNA biomarker panel discovery (including liquid biopsies) to the development of a PCR-based molecular diagnostic test. Biogazelle also serves as a specialty lab in the field of clinical trials and in routine diagnostic settings.

PharmaFluidics

Venture Round in 2014
PharmaFluidics is a Brussels-based spin-off from the Vrije Universiteit Brussel, focusing on developing and manufacturing micro-chip based chromatography columns for use in biomarker, diagnostics, and drug research applications. The company leverages its expertise in chemical engineering and micro-fabrication technology to create high-quality solutions tailored for mixing, separation, and reaction processes at milli- to nano-scales. Their products enable researchers to identify active compounds in complex biological samples more efficiently and sensitively.

Track4c

Venture Round in 2014
Track4C, founded in 2012, specializes in providing comprehensive container and cargo tracking services aimed at enhancing supply chain transparency. The company develops affordable and effective solutions that integrate hardware and software tools for tracking containers or fleets. Utilizing GSM technology, Track4C enables clients to access a web-based dashboard that facilitates seamless interfacing with existing ICT systems. This integration significantly reduces administrative burdens and operational costs for businesses. Supported by a network of business incubators and backed by prominent venture capital firms in Belgium, Track4C is led by a management team with extensive experience in telecommunications and various sectors.

CoScale

Seed Round in 2014
CoScale is a developer of a comprehensive performance monitoring platform tailored for production environments. The platform continuously tracks servers, containers, and applications, providing insights into their effects on user experience and key business metrics. By employing automated anomaly detection and contextual insights, CoScale simplifies the monitoring and troubleshooting processes for its users, enabling proactive responses to performance issues that could adversely impact business outcomes. The platform is designed for use by DevOps engineers, application owners, and business professionals, all of whom aim to enhance digital performance by ensuring faster and more reliable websites and applications. This ultimately leads to improved user experiences and increased conversion rates.

Multiplicom

Venture Round in 2013
Multiplicom is a company that specializes in the development of molecular diagnostics products specifically tailored for medical genetics. It manufactures molecular diagnostic kits that facilitate the collection of genetic information, allowing for early identification of congenital defects during pregnancy. By focusing on effective, affordable, and personalized medicine, Multiplicom aims to enhance patient care through advanced clinical laboratory-based tests. Its products are designed to empower healthcare providers and patients with critical genetic insights, contributing to more informed treatment decisions.

Eyeo

Eyeo is fundamentally redefining image sensing by eliminating decades-old limitations, Capturing all incoming light and drastically improving resolution.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.